- Report
- February 2023
- 198 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- February 2023
- 99 Pages
Global
From €3813EUR$3,950USD£3,270GBP
- Report
- February 2023
- 174 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- October 2022
- 119 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- August 2018
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- March 2020
- 44 Pages
Global
€1272EUR$1,318USD£1,091GBP
- Report
- August 2022
United States
From €1872EUR$1,940USD£1,606GBP
- Report
- August 2022
Global
From €956EUR$990USD£820GBP
- Report
- August 2021
Global
From €3851EUR$3,990USD£3,304GBP
- Report
- August 2021
Europe
From €3301EUR$3,420USD£2,832GBP
- Report
- February 2021
Global
From €2857EUR$2,960USD£2,451GBP
- Report
- July 2022
- 639 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Clinical Trials
- January 2020
- 524 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- September 2022
- 149 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- September 2022
- 71 Pages
Asia Pacific
From €1448EUR$1,500USD£1,242GBP
- Report
- September 2022
- 71 Pages
Europe
From €1448EUR$1,500USD£1,242GBP
- Report
- September 2022
- 65 Pages
North America
From €1448EUR$1,500USD£1,242GBP
- Report
- September 2022
- 71 Pages
Middle East, Africa
From €1448EUR$1,500USD£1,242GBP
- Drug Pipelines
- November 2020
- 164 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- February 2022
- 274 Pages
Global
From €4343EUR$4,500USD£3,726GBP
The Insomnia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Insomnia drugs are used to treat difficulty sleeping, and can be divided into two categories: sedative-hypnotics and non-sedative hypnotics. Sedative-hypnotics are drugs that act on the central nervous system to induce sleep, while non-sedative hypnotics are drugs that act on the brain to improve sleep quality without causing sedation. Commonly prescribed insomnia drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
Some companies in the Insomnia Drug market include Sanofi, Pfizer, Merck, GlaxoSmithKline, and Takeda. Show Less Read more